Systematic review and meta-analysis of vancomycin therapeutic level for treatment of vancomycin-sensitive enterococcal infections.

24 and Sasano and Hanada, 20 in which 87.7% and 63.4% of patients had solid or haematologic malignancies, reduced heterogeneity and showed a trend toward lower mortality rate among individuals with high trough vancomycin regimen (OR 0.62, 95% CI 0.29–1.33, I 2 = 49%) (Figure 2B ) (Figure S2B , Supplementary Appendix 3 ).

also in 53,322 other papers